Ethical considerations in clinical training, care and research in psychopharmacology

被引:2
作者
Strous, Rael D. [1 ,2 ]
机构
[1] Beer Yaakov Mental Hlth Ctr, Chron Inpatient Unit, IL-70350 Beer Yaagov, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
关键词
Ethics; informed consent; mindfulness; psychopharmacology; responsibility; PSYCHOSIS RISK SYNDROME; DEEP BRAIN-STIMULATION; CONFLICTS-OF-INTEREST; MENTAL-ILLNESS; SCHIZOPHRENIA RESEARCH; PSYCHIATRIC RESEARCH; MEDICAL-ETHICS; DSM-V; ISSUES; CONSENT;
D O I
10.1017/S1461145710001112
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Psychopharmacology is a powerful tool in psychiatry; however, it is one that demands responsibility in order to deal with the ethical complexities that accompany advances in the field. It is important that questions are asked and that ethical mindfulness and sensitivity are developed along with clinical skills. In order to cultivate and deepen ethical awareness and subsequently solve issues in optimal fashion, investment should be made in the development of an ethical decision-making process as well as in education in the ethics of psychopharmacology to trainees in the field at all stages of their educational development. A clear approach to identifying ethical problems, engaging various ethical concepts in considering solutions and then applying these principles in problem resolution is demanded. An openness in identifying and exploring issues has become crucial to the future development and maturation of psychopharmacologists, both research and clinical. Consideration must be given to the social implications of psychopharmacological practice, with the best interests of patients always paramount. From both a research and clinical perspective, psychopharmacology has to be practised with fairness, sensitivity and ethical relevance to all. While ethical issues related to psychopharmacological practice are varied and plentiful, this review focuses on advances in technology and biological sciences, personal integrity, special populations, and education and training.
引用
收藏
页码:413 / 424
页数:12
相关论文
共 67 条
[31]   It is time to take a stand for medical research and against terrorism targeting medical scientists [J].
Krystal, John H. ;
Carter, Cameron S. ;
Geschwind, Daniel ;
Manji, Husseini K. ;
March, John S. ;
Nestler, Eric J. ;
Zubieta, Jon-Kar ;
Charney, Dennis S. ;
Goldman, David ;
Gur, Raquel E. ;
Lieberman, Jeffrey A. ;
Roy-Byrne, Peter ;
Rubinow, David R. ;
Anderson, Stewart A. ;
Barondes, Samuel ;
Berman, Karen F. ;
Blair, James ;
Braff, David L. ;
Brown, E. Sherwood ;
Calabrese, Joseph R. ;
Carlezon, William A., Jr. ;
Cook, Edwin H., Jr. ;
Davidson, Richard J. ;
Davis, Michael ;
Desimone, Robert ;
Drevets, Wayne C. ;
Duman, Ronald S. ;
Essock, Susan M. ;
Faraone, Stephen V. ;
Freedman, Robert ;
Friston, Karl J. ;
Gelernter, Joel ;
Geller, Barbara ;
Gill, Michael ;
Gould, Elizabeth ;
Grace, Anthony A. ;
Grillon, Christian ;
Gueorguieva, Ralitza ;
Hariri, Ahmad R. ;
Innis, Robert B. ;
Jones, Edward G. ;
Kleinman, Joel E. ;
Koob, George F. ;
Krystal, Andrew D. ;
Leibenluft, Ellen ;
Levinson, Douglas F. ;
Levitt, Pat R. ;
Lewis, David A. ;
Liberzon, Israel ;
Lipska, Barbara K. .
BIOLOGICAL PSYCHIATRY, 2008, 63 (08) :725-727
[32]   The Impact of Disclosing Financial Ties in Research and Clinical Care A Systematic Review [J].
Licurse, Adam ;
Barber, Emma ;
Joffe, Steve ;
Gross, Cary .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (08) :675-+
[33]  
Lifton R., 1986, Nazi Doctors: Medical killing and the psychology of genocide
[34]   THE INTERNATIONAL DIMENSIONS OF NEUROETHICS [J].
Lombera, Sofia ;
Illes, Judy .
DEVELOPING WORLD BIOETHICS, 2009, 9 (02) :57-64
[35]   Financial capacity in persons with schizophrenia and serious mental illness: Clinical and research ethics aspects [J].
Marson, DC ;
Savage, R ;
Phillips, J .
SCHIZOPHRENIA BULLETIN, 2006, 32 (01) :81-91
[36]   Ethical issues in psychopharmacology [J].
McHenry, L. .
JOURNAL OF MEDICAL ETHICS, 2006, 32 (07) :405-410
[37]  
Merkel Reinhard., 2007, Intervening in the Brain: Changing Psyche and Society
[38]   Psychopharmacological research ethics: special issues affecting US ethnic minorities [J].
Miskimen, T ;
Marin, H ;
Escobar, J .
PSYCHOPHARMACOLOGY, 2003, 171 (01) :98-104
[39]   Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry [J].
Mitchell, Philip B. .
MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (05) :273-275
[40]   Ethics in action: Ethical principles for doing qualitative health research [J].
Morse, Janice M. .
QUALITATIVE HEALTH RESEARCH, 2007, 17 (08) :1003-1005